Autonomix Medical, Inc.

AMIX Nasdaq SEC CIK 1617867
Follow Autonomix Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q2 2027 USD · US GAAP
Revenue, last quarter $0
Net income −$3.1M +58% vs same quarter last year
EPS, diluted −$2.51
Operating cash flow −$2.6M +31.5% vs same quarter last year
Revenue by quarter
$0
$0
$0
$0
$0
$0
$0
$0
Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27 Q2 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income5 fiscal years
  • Revenue
  • Net income
−$20M−$15M−$10M−$5M$0FY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$0−$16.7M
FY25$0−$11.4M
FY24$0−$15.4M
FY23$0−$2M
FY22--
Free cash flowOperating cash flow minus capital expenditure
−$15M−$10M−$5M$0FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26−$12.3M
FY25−$8.3M
FY24−$6.6M
FY23−$1.9M
FY22-